Inactive Instrument

Other languages Arix Bioscience plc

Equities

ARIX

GB00BD045071

Other languages

Unlock all the news: Be the first to know and act before the market!

Merck Sharp & Dohme LLC completed the acquisition of Harpoon Therapeutics, Inc..	Mar. 10
RTW Biotech Opportunities NAV increases 2.5% in January	Feb. 14
RTW Biotech Opportunities Completes Arix Bioscience Acquisition	Feb. 13
RTW Biotech Opportunities Ltd a fund managed by RTW Investments, LP completed the acquisition of Arix Biosciences Plc's assets from Arix Bioscience plc.	Feb. 12
Katoro Gold launches fundraising, eyes board shake-up	Feb. 12
Arix Bioscience's Asset Sale to RTW Biotech Takes Effect	Feb. 12
Arix Bioscience shares suspended ahead of RTW takeover	Feb. 12
Arix Bioscience Shares to be Suspended on London Exchange Amid Acquisition	Feb. 12
Arix Bioscience Shareholders Approve Asset Sale to RTW Biotech	Jan. 29
Arix Bioscience Gains UK Regulatory Approval for Sale to RTW Biotech	Jan. 23
RTW Biotech completes Arix investment in takeover run-up	Jan. 22
Arix Bioscience plc Announces Resignation of Directors	Jan. 22
Arix Bioscience eyes USD19 million return from Harpoon sale	Jan. 19
Arix Bioscience Flags Proceeds from Merck's Purchase of Harpoon Therapeutics	Jan. 19
Rtw Biotech Opportunities Operating Ltd completed the acquisition of a 26.6% stake in Arix Bioscience plc from Acacia Research Corporation for £47.2 million.	Jan. 18
Arix Bioscience's Portfolio Company Signs $680 Million Takeover Deal with Merck & Co.	Jan. 08
Arix Bioscience's Portfolio Company Doses First Patient in Late-stage Trial of Choroidal Melanoma Therapy	Dec. 08
RTW Biotech agrees "immediately accretive" Arix Bioscience takeover	Nov. 01
RTW Biotech Opportunities, Arix Bioscience Agree on Potential Merger Terms	Nov. 01
Gran Tierra completes offers, Pensana wins grant	23-10-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Arix Bioscience plc

Equities

ARIX

GB00BD045071

Other languages

Filters